Omniab Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Omniab Inc inventory turnover ratio, the Omniab Inc 's ability to sell and replace its inventory in the third quarter 2026, sequentially increased to 1.17 in the third quarter 2026, OABI's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Omniab Inc in Sep 30 2026 quarter, has decreased to 312 days, compare to 579 days, in the Jun 30 2026 quarter.

Within Healthcare sector Omniab Inc achieved the highest inventory turnover ratio. While inventory turnover ranking remained unchanged in the Third Quarter 2026 compared to previous quarter at no. .

OABI Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Omniab Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

OABI Inventory Turnover Ratio	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Inventory Growth	-	220.57 %	-	-	-
Y / Y Cost of Sales Growth	2031.03 %	-	-	-	-
Inventory Turnover Ratio (TTM)	1.17	-	0.96	-	-
OABI's Total Ranking	#	#	#	#	#
Average inventory processing period	312	-	381	-	-
Seq. Inventory Growth	6.02 %	0 %	-	-	-
Seq. Cost of Sales Growth	-	-	-94.53 %	844.83 %	-

Inventory Turnover Ratio Company Ranking
Within:	No.
Medical Laboratories Industry	#
Healthcare Sector	#
Overall Market	#

Inventory Turnover Ratio Statistics
High	Average	Low
0	0	0

OABI Company Profile >> Back to OABI Efficiency Comparisons >> Compare OABI Inventory Turnover Ratio to its Competitors

Financial Statements
Omniab Inc 's Inventories	$ 1 Millions	Visit OABI's Balance sheet
Omniab Inc 's Cost of Revenues TTM	$ 1 Millions	Visit OABI's Income Statement
What are OABI's Sales?		Visit OABI's Sales by Segment

Other Inventory Turnover Ratios
Omniab Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Laboratories Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
OABI's Inventory Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for OABI's Competitors
Inventory Turnover Ratio for OABI's Suppliers
Inventory Turnover Ratio for OABI's Customers

You may also want to know
OABI's Sales Growth Rates	OABI's Pe Price to earnings ratio	OABI's Receivables Turnover Ratio	OABI's Stock Quote
OABI's Net Income Growth Rates	OABI's Ps Price to Sales ratio	OABI's Sales per Employee	OABI's Asset Turnover Ratio
OABI's Net Margin	OABI's Pb Price to Book ratio	OABI's Financial Strength Ratios	OABI's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Sep 30 2026	Inventories at quarter ending Sep 30 2026
Beta Bionics Inc	2.31	$ 53.285 Millions	$ 23 Millions
Merit Medical Systems Inc	2.25	$ 817.001 Millions	$ 363 Millions
Rigel Pharmaceuticals Inc	2.24	$ 29.869 Millions	$ 13 Millions
Bioventus Inc	2.24	$ 183.856 Millions	$ 82 Millions
Johnson and Johnson	2.17	$ 32,222.000 Millions	$ 14,824 Millions
Orasure Technologies Inc	2.17	$ 66.055 Millions	$ 30 Millions
Standard Biotools Inc	2.16	$ 39.539 Millions	$ 18 Millions
Adc Therapeutics Sa	2.14	$ 5.857 Millions	$ 3 Millions
Icu Medical Inc	2.14	$ 1,304.538 Millions	$ 609 Millions
Glaukos Corp	2.13	$ 131.180 Millions	$ 62 Millions
Halozyme Therapeutics Inc	2.13	$ 319.654 Millions	$ 150 Millions
Organon and Co	2.08	$ 2,859.000 Millions	$ 1,371 Millions
Repligen Corp	2.07	$ 372.472 Millions	$ 180 Millions
Boston Scientific Corporation	2.06	$ 6,502.000 Millions	$ 3,153 Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________	2.03	$ 16.819 Millions	$ 8 Millions
Bausch and Lomb Corp	2.01	$ 1,986.000 Millions	$ 990 Millions
Clearpoint Neuro Inc	1.98	$ 17.564 Millions	$ 9 Millions
Alpha Pro Tech Ltd	1.97	$ 40.363 Millions	$ 21 Millions
Intuitive Surgical Inc	1.91	$ 3,799.300 Millions	$ 1,986 Millions
Indivior Pharmaceuticals Inc	1.88	$ 208.000 Millions	$ 111 Millions
Tenet Healthcare Corp	1.88	$ 642.000 Millions	$ 342 Millions
Trisalus Life Sciences Inc	1.86	$ 7.291 Millions	$ 4 Millions
Elutia Inc	1.84	$ 3.772 Millions	$ 2 Millions
Amgen Inc	1.81	$ 11,319.000 Millions	$ 6,255 Millions
Haemonetics Corporation	1.80	$ 558.423 Millions	$ 310 Millions
Orthofix Medical Inc	1.78	$ 244.423 Millions	$ 137 Millions
Iradimed Corporation	1.78	$ 21.878 Millions	$ 12 Millions
Harvard Bioscience Inc	1.76	$ 38.986 Millions	$ 22 Millions
Ceribell Inc	1.74	$ 12.160 Millions	$ 7 Millions
Axsome Therapeutics Inc	1.67	$ 58.422 Millions	$ 35 Millions

Date modified: 2026-10-31T17:31:39+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.